Evidence map›Paper›PMID 25290377›Full record

ArticlePloS one2014

Methamphetamine alters the normal progression by inducing cell cycle arrest in astrocytes.

Austin R Jackson, Ankit Shah, Anil Kumar

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Austin R JacksonDivision of Pharmacology and Toxicology, University of Missouri-Kansas City School of Pharmacy, Kansas City, Missouri, United States of America.
Ankit ShahDivision of Pharmacology and Toxicology, University of Missouri-Kansas City School of Pharmacy, Kansas City, Missouri, United States of America.
Anil KumarDivision of Pharmacology and Toxicology, University of Missouri-Kansas City School of Pharmacy, Kansas City, Missouri, United States of America.
University of Missouri–Kansas City · US

Funding

Methamphetamine and AIDS in a Non-Human Primate ModelR01DA025011 · NIDA · UNIVERSITY OF MISSOURI KANSAS CITY · PI KUMAR, ANIL · 2008 to 2014
$1.8M
HIV, Drug Abuse and NeurotoxicityR01DA025528 · NIDA · UNIVERSITY OF MISSOURI KANSAS CITY · PI KUMAR, ANIL · 2009 to 2013
$1.4M
NIDA NIH HHS DA025011NIDA NIH HHS DA025528NIDA NIH HHS R01 DA025011NIDA NIH HHS R01 DA025528
6 · The paper itself

Abstract

Methamphetamine (MA) is a potent psychostimulant with a high addictive capacity, which induces many deleterious effects on the brain. Chronic MA abuse leads to cognitive dysfunction and motor impairment. MA affects many cells in the brain, but the effects on astrocytes of repeated MA exposure is not well understood. In this report, we used Gene chip array to analyze the changes in the gene expression profile of primary human astrocytes treated with MA for 3 days. Range of genes were found to be differentially regulated, with a large number of genes significantly downregulated, including NEK2, TTK, TOP2A, and CCNE2. Gene ontology and pathway analysis showed a highly significant clustering of genes involved in cell cycle progression and DNA replication. Further pathway analysis showed that the genes downregulated by multiple MA treatment were critical for G2/M phase progression and G1/S transition. Cell cycle analysis of SVG astrocytes showed a significant reduction in the percentage of cell in the G2/M phase with a concomitant increase in G1 percentage. This was consistent with the gene array and validation data, which showed that repeated MA treatment downregulated the genes associated with cell cycle regulation. This is a novel finding, which explains the effect of MA treatment on astrocytes and has clear implication in neuroinflammation among the drug abusers.

Indexed as

Antigens, NeoplasmAstrocytesCell Cycle CheckpointsCell Cycle ProteinsCyclinsDNA-Binding ProteinsDNA ReplicationDNA Topoisomerases, Type IIGene Expression ProfilingGene Expression RegulationHumansMethamphetamineMolecular Sequence AnnotationMultigene FamilyNIMA-Related KinasesOligonucleotide Array Sequence AnalysisAntigens, NeoplasmCCNE2 protein, humanCell Cycle ProteinsCyclinsDNA-Binding ProteinsDNA Topoisomerases, Type IIMethamphetamineNEK2 protein, humanNIMA-Related KinasesPoly-ADP-Ribose Binding ProteinsProtein Serine-Threonine KinasesProtein-Tyrosine KinasesSympathomimeticsTOP2A protein, humanTTK protein, human

Identifiers

PMID25290377
PMCPMC4188627
OpenAlexW2018769669

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.